SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-065389
Filing Date
2017-11-02
Accepted
2017-11-02 08:00:11
Documents
3
Period of Report
2017-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-24993_18k.htm 8-K 26953
2 EX-99.1 a17-24993_1ex99d1.htm EX-99.1 194817
3 GRAPHIC g249931mmi001.jpg GRAPHIC 5112
  Complete submission text file 0001104659-17-065389.txt   230236
Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37368 | Film No.: 171170786
SIC: 2836 Biological Products, (No Diagnostic Substances)